Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

More articles from Clinical Review

  • You have access
    Stress echocardiography: its emerging role in identifying viable myocardium
    Curtis M. Rimmerman, MD
    Cleveland Clinic Journal of Medicine July 1995, 62 (4) 235-239;

    In patients with chronic ischemia or left ventricular systolic dysfunction, this test can indicate whether the damaged myocardium is still viable and, therefore, whether revascularization would be beneficial.

  • You have access
    Dopamine agonists in the treatment of Parkinson’s disease
    Rajesh Pahwa, MD and William C. Koller, MD, PHD
    Cleveland Clinic Journal of Medicine July 1995, 62 (4) 212-217;

    Bromocriptine or pergolide can control symptoms when used alone or as an adjunct to Levodopa therapy, and can permit a lowering of the levodopa dose.

  • You have access
    Current status of stress echocardiography in the diagnosis of coronary artery disease
    Thomas Marwick, MD
    Cleveland Clinic Journal of Medicine July 1995, 62 (4) 227-234;

    Electrocardiography with exercise or pharmacologic stress is gaining clinical acceptance, but its accuracy depends on the expertise of the people who perform it.

  • You have access
    Pathogenesis of epilepsy: the role of excitatory amino acids
    Gregory L. Holmes, MD
    Cleveland Clinic Journal of Medicine July 1995, 62 (4) 240-247;

    These neurotransmitters seem to play a role in brain development—and also in seizures. Experimental drugs can block their action.

  • You have access
    Office evaluation and treatment of Raynaud's phenomenon
    Marcy B. Bolster, MD, Hildegard R. Maricq, MD and Richard L. Leff, MD
    Cleveland Clinic Journal of Medicine January 1995, 62 (1) 51-61;

Pages

  • Previous
  • 1
  • 2
  • 3

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire